|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| OPERATING ACTIVITIES | |||||
| Net income | |||||
| Adjustments to reconcile net income to net cash provided by operating activities: | |||||
| Gain on sale of branches | |||||
| Provision for credit losses | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Accretion of discounts, net | |||||
| Origination of loans to be sold | |||||
| Proceeds from loan sales | |||||
| Gain on sale of loans | |||||
| Share-based and deferred compensation | |||||
| Bank-owned life insurance income | |||||
| Gain on sale of debt securities, available for sale | |||||
| Change in accrued interest receivable and other assets | |||||
| Change in accrued interest payable and other liabilities | |||||
| Other, net | |||||
| Net cash provided by operating activities | |||||
| INVESTING ACTIVITIES | |||||
| Investment securities available for sale: | |||||
| Proceeds from sales | |||||
| Proceeds from calls and maturities | |||||
| Proceeds from principal repayments | |||||
| Purchases | |||||
| Investment securities held to maturity | |||||
| Proceeds from principal repayments | |||||
| Purchases | |||||
| Proceeds from redemptions of certificates of deposit with other banks | |||||
| Purchase of restricted investment in bank stocks | |||||
| Redemption of restricted investment in bank stocks | |||||
| Increase in loans, net | |||||
| Purchase of bank-owned life insurance | |||||
| Payment of death benefit under bank owned life insurance | |||||
| Cash paid to buy-out minority interest | |||||
| Proceeds from disposal of premises and equipment | |||||
| Purchase of premises and equipment | |||||
| Proceeds from sale of branches, net | |||||
| Purchase of computer software | |||||
| Net cash acquired through merger and acquisition | |||||
| Net cash provided by (used in) investing activities | |||||
| FINANCING ACTIVITIES | |||||
| Increase in deposits, net | |||||
| Change in short-term borrowings, net | |||||
| Proceeds from long-term borrowings | |||||
| Issuance of shares from exercise of stock options | |||||
| Dividends paid | |||||
| Net proceeds from issuance of common stock | |||||
| Net cash provided by (used in) financing activities | |||||
| (Decrease) increase in cash and cash equivalents | |||||
| CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD | |||||
| CASH AND CASH EQUIVALENTS AT END OF PERIOD | |||||
| SUPPLEMENTAL CASH FLOW DISCLOSURES | |||||
| Interest | |||||
| Income taxes | |||||
| Federal income taxes | |||||
| State income taxes | |||||
| Reclassification of New Jersey branch loans from portfolio loans to assets held-for-sale, net | |||||
| Reclassification of New Jersey branch assets to assets held-for-sale | |||||
| Reclassification of New Jersey branch assets to assets held-for-sale, net | |||||
| Reclassification of New Jersey branch deposits to liabilities held-for-sale, net | |||||
| Reclassification of New Jersey branch liabilities to liabilities held-for-sale | |||||
| Securities available for sale | |||||
| Loans | |||||
| Investments in restricted bank stock | |||||
| Premises and equipment | |||||
| Right-of-Use Asset | |||||
| Bank-owned life insurance | |||||
| Goodwill | |||||
| Intangible Assets | |||||
| Deferred tax assets | |||||
| Accrued interest receivable and other assets | |||||
| Deposits | |||||
| Other borrowings | |||||
| Subordinated debt | |||||
| Operating lease liabilities | |||||
| Accrued interest payable and other liabilities | |||||
| Net non-cash assets acquired | |||||
| Cash and cash equivalents acquired | |||||
| Reclassification of New Jersey branch liabilities to liabilities held-for-sale, net | |||||
Loading...